Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-002582-39-IT
EUCTR2006-002582-39-IT
Active, not recruiting
Not Applicable

A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with undetectable plasma viremia. - SNODO

FONDAZIONE NADIR ONLUS0 sites200 target enrollmentAugust 30, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsVIRAMUNE*60 CPR 200 MG

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
FONDAZIONE NADIR ONLUS
Enrollment
200
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 30, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
FONDAZIONE NADIR ONLUS

Eligibility Criteria

Inclusion Criteria

  • •HIV\-1 documented infection Age 18 and 65 years Current therapy with a HAART including 1 PI ritonavir and 2 NRTIs Any CD4 cell count see exclusion criteria for female patients Plasma HIV\-RNA 50 copies/mL for at least 6 months before randomization Stable clinical conditions
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Active opportunistic infections, neoplasms, acute viral hepatitis, drug or alcohol abuse. Chronic hepatitis caused by HBV od HCV is not a cause for exclusion CD4 cell count 250 cells/microliter in female subjects Unability to give and/or to maintain an informed consent Previous NNRTI treatment that was discontinued due to virologic failure Previous nevirapine treatment that was discontinued due to intolerance and/or toxicity

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Influence of Inhaled Aviptadil on Cough and Quality of life in Sarcoidosis
EUCTR2017-004219-37-DEniversitätsklinikum Freiburg, Leitender Ärztlicher Direktor200
Not yet recruiting
Phase 4
A prospective, multicenter, randomized, controlled study to evaluate the clinical outcome of Zhenyuan capsule in the treatment of heart failure after myocardial infarctioHeart failure after myocardial infarction
ITMCTR2200005706Zhongshan Hospital affiliated to Fudan University
Active, not recruiting
Not Applicable
Multiple-center clinical trial comparing surgical and conservative treatment in patients with anterior temporomandibular disc displacement without reductioAnterior disc displacement of the temporomandibular joint without reductionMusculoskeletal Diseases
ISRCTN99353996West China Medical Center of Sichuan University90
Recruiting
Phase 4
A multi center, prospective, randomized controlled trial comparing cervical arthroplasty to anterior cervical discectomy and fusion (ACDF) for the treatment of cervical degenerative disc disease.Cervical disc disease10019190
NL-OMON39490Johnson & Johnson50
Not yet recruiting
Phase 4
A multi-center clinical study of integrated Traditional Chinese and Western medicine in the management of atherosclerotic cardiovascular disease
ITMCTR2000003930Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM